Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[68Ga]Ga-FAPI PET/CT in Gastric and GEJ Cancer
NCT05898854Phase 2Completed
- Sponsor
- Aalborg University Hospital
- Start
- Feb 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-blind, single-arm trial of 68Ga FAPI-46 in gastric cancer (GC) and gastroesophageal junction cancer, sponsored by Aalborg University Hospital. Primary endpoints: Diagnostic accuracy at 1.5 years, Staging at 1.5 years and 1 more. Started Feb 2024; status: completed.
02
Drugs
68Ga FAPI-46
03
Conditions
gastric cancer (GC)gastroesophageal junction cancer
Beyond the preview
Go deeper on NCT05898854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05898854.